St. Jude Medical has announced it has received FDA approval of its Assura portfolio of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators, according to a news ...

St. Jude Medical has issued a warning regarding its implanted defibrillators after reports that a malfunction was linked to two patient deaths. The company said they could stop working after rapidly ...

SAN FRANCISCO (MarketWatch) -- St. Jude Medical Inc. said after Monday's closing bell that it has notified physicians that some of its implantable cardioverter defibrillators are in need of a ...

St. Jude Medical, based in St. Paul, Minn., has agreed to pay the federal government $16 million to resolve allegations that the company used post-market studies and a registry to pay kickbacks to ...

The National Republican Congressional Committee is attacking a Democratic medical executive running for Congress for her involvement with St. Jude Medical, a company that has come under fire for ...

Aug 21 (Reuters) - Changes that St. Jude Medical Inc made to its heart defibrillator leads do not protect against insulation defects that could potentially lead to device failure and death, according ...

January 21, 2011 (Boston, Massachusetts) — Device maker St Jude Medical is paying $16 million to settle a civil suit, resolving allegations that the company paid kickbacks to physicians to implant ...

St. Jude Medical, a medical device company based in St. Paul, Minn., has agreed to pay $3.65 million to resolve allegations that it inflated the cost of pacemakers and defibrillators purchased by the ...

St. Jude Medical Inc. has announced the first European enrollments in its Nanostim Leadless Pacemaker Observational Study as it moves forward with efforts to commercialize next-generation pacemaker ...

St. Jude Medical announced it has appointed Population Health Research Institute, PHRI,, an academic health science research institute, to analyze data from three combined registries on the Riata ST ...

CHICAGO, July 22 (Reuters) - Medical device maker St. Jude Medical Inc reported better-than-expected quarterly results on Thursday, helped by rival Boston Scientific Corp's one-month halt in shipments ...

St. Jude Medical (NYSE:STJ) announced Monday that it has won regulatory approval from the European Union to market a smaller implantable cardioverter defibrillator. The Ellipse is the industry’s ...